Alivus Life Sciences Limited (NSE:ALIVUS)
India · Delayed Price · Currency is INR 1,075.15
+7.10 (0.66%)
Apr 21, 2026, 3:20 PM IST
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 131.09 billion as of April 21, 2026. Its market cap has increased by 6.52% in one year.
Market Cap
131.09B
Enterprise Value
125.17B
Revenue
25.12B
Ranking
n/a
PE Ratio
24.15
Stock Price
1,075.15
Market Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 131.09B, an increase of 42.94%. That is a compound annual growth rate of 7.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 131.09B | 16.58% |
| Dec 31, 2025 | 112.45B | -6.68% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
| Aug 6, 2021 | 91.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gland Pharma | 296.13B |
| Wockhardt | 226.73B |
| NATCO Pharma | 200.55B |
| Eris Lifesciences | 200.26B |
| Piramal Pharma | 197.65B |
| Alembic Pharmaceuticals | 154.25B |
| Cohance Lifesciences | 149.41B |
| Strides Pharma Science | 92.20B |